S
StemRIM Inc
TSE:4599
StemRIM Inc
TSE:4599
Price:
319
JPY
0.63%
Market Closed
Market Cap:
¥20B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
StemRIM Inc
TSE:4599
|
JP |
|
Indofood CBP Sukses Makmur Tbk PT
IDX:ICBP
|
ID |
|
N
|
Nanosphere Health Sciences Inc
CNSX:NSHS
|
US |
|
Genting Bhd
OTC:GEBEY
|
MY |
Income Statement
Earnings Waterfall
StemRIM Inc
StemRIM Inc
Income Statement
StemRIM Inc
StemRIM Inc
Currency: JPY
| Jan-2020 | Apr-2020 | Jul-2020 | Oct-2020 | Jan-2021 | Apr-2021 | Jul-2021 | Oct-2021 | Jan-2022 | Apr-2022 | Jul-2022 | Oct-2022 | Jan-2023 | Apr-2023 | Jul-2023 | Oct-2023 | Jan-2024 | Apr-2024 | Jul-2024 | Oct-2024 | Jan-2025 | Apr-2025 | Jul-2025 | Oct-2025 | Jan-2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
400
N/A
|
2 100
+425%
|
2 310
+10%
|
2 310
N/A
|
1 910
-17%
|
1 400
-27%
|
1 213
-13%
|
1 213
N/A
|
1 213
N/A
|
23
-98%
|
0
N/A
|
0
N/A
|
2 350
N/A
|
2 350
N/A
|
2 350
N/A
|
2 350
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||||
| Operating Expenses |
(248)
|
(575)
|
(1 684)
|
(1 946)
|
(2 206)
|
(2 397)
|
(1 994)
|
(2 028)
|
(2 036)
|
(2 019)
|
(2 004)
|
(1 977)
|
(2 016)
|
(2 069)
|
(2 208)
|
(2 186)
|
(2 199)
|
(2 165)
|
(2 076)
|
(2 158)
|
(2 108)
|
(2 036)
|
(1 972)
|
(1 940)
|
(1 898)
|
|
| Selling, General & Administrative |
(57)
|
(153)
|
(320)
|
(392)
|
(444)
|
(467)
|
(436)
|
(506)
|
(550)
|
(580)
|
(549)
|
(571)
|
(579)
|
(590)
|
(609)
|
(641)
|
(639)
|
(627)
|
(594)
|
(673)
|
(647)
|
(606)
|
(548)
|
(517)
|
(495)
|
|
| Research & Development |
(192)
|
(421)
|
(1 356)
|
(1 554)
|
0
|
(1 530)
|
(1 514)
|
(1 122)
|
(1 486)
|
(1 439)
|
(1 405)
|
(1 433)
|
(1 438)
|
(1 479)
|
(1 551)
|
(1 545)
|
(1 560)
|
(1 538)
|
(1 438)
|
(1 485)
|
(1 461)
|
(1 429)
|
(1 374)
|
(1 423)
|
(1 404)
|
|
| Depreciation & Amortization |
0
|
0
|
(8)
|
0
|
0
|
0
|
(44)
|
0
|
0
|
0
|
(49)
|
0
|
0
|
0
|
(48)
|
0
|
0
|
0
|
(44)
|
0
|
0
|
0
|
(49)
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
(0)
|
(0)
|
(1 762)
|
(400)
|
0
|
(400)
|
0
|
0
|
0
|
26
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Operating Income |
(248)
N/A
|
(175)
+30%
|
416
N/A
|
364
-12%
|
104
-72%
|
(487)
N/A
|
(594)
-22%
|
(815)
-37%
|
(823)
-1%
|
(806)
+2%
|
(1 981)
-146%
|
(1 977)
+0%
|
(2 016)
-2%
|
281
N/A
|
142
-49%
|
164
+15%
|
151
-8%
|
(2 165)
N/A
|
(2 076)
+4%
|
(2 158)
-4%
|
(2 108)
+2%
|
(2 036)
+3%
|
(1 972)
+3%
|
(1 940)
+2%
|
(1 898)
+2%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
1
|
1
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
11
|
22
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
8
|
8
|
8
|
8
|
0
|
0
|
0
|
26
|
0
|
51
|
51
|
25
|
50
|
30
|
36
|
59
|
47
|
48
|
68
|
43
|
33
|
55
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
3
|
3
|
(54)
|
0
|
(5)
|
(5)
|
10
|
10
|
13
|
21
|
8
|
9
|
10
|
2
|
2
|
2
|
0
|
(0)
|
(2)
|
(2)
|
(1)
|
(1)
|
1
|
1
|
12
|
|
| Pre-Tax Income |
(246)
N/A
|
(172)
+30%
|
361
N/A
|
372
+3%
|
106
-71%
|
(485)
N/A
|
(576)
-19%
|
(805)
-40%
|
(810)
-1%
|
(785)
+3%
|
(1 946)
-148%
|
(1 969)
-1%
|
(1 955)
+1%
|
335
N/A
|
170
-49%
|
217
+27%
|
181
-16%
|
(2 129)
N/A
|
(2 019)
+5%
|
(2 112)
-5%
|
(2 062)
+2%
|
(1 969)
+4%
|
(1 928)
+2%
|
(1 895)
+2%
|
(1 809)
+5%
|
|
| Net Income | ||||||||||||||||||||||||||
| Tax Provision |
(1)
|
(2)
|
(13)
|
(13)
|
(16)
|
(16)
|
(6)
|
(6)
|
(4)
|
(4)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(0)
|
|
| Income from Continuing Operations |
(247)
|
(174)
|
348
|
358
|
90
|
(501)
|
(582)
|
(812)
|
(814)
|
(789)
|
(1 948)
|
(1 971)
|
(1 957)
|
333
|
168
|
215
|
179
|
(2 131)
|
(2 022)
|
(2 115)
|
(2 065)
|
(1 973)
|
(1 929)
|
(1 897)
|
(1 809)
|
|
| Net Income (Common) |
(247)
N/A
|
(174)
+29%
|
348
N/A
|
358
+3%
|
90
-75%
|
(501)
N/A
|
(582)
-16%
|
(812)
-39%
|
(814)
0%
|
(789)
+3%
|
(1 948)
-147%
|
(1 971)
-1%
|
(1 957)
+1%
|
333
N/A
|
168
-49%
|
215
+28%
|
179
-16%
|
(2 131)
N/A
|
(2 022)
+5%
|
(2 115)
-5%
|
(2 065)
+2%
|
(1 973)
+4%
|
(1 929)
+2%
|
(1 897)
+2%
|
(1 809)
+5%
|
|
| EPS (Diluted) |
-4.67
N/A
|
-3.14
+33%
|
5.74
N/A
|
6.28
+9%
|
1.55
-75%
|
-8.51
N/A
|
-10.02
-18%
|
-13.76
-37%
|
-13.78
0%
|
-13.27
+4%
|
-32.92
-148%
|
-33.09
-1%
|
-32.7
+1%
|
4.88
N/A
|
2.69
-45%
|
3.52
+31%
|
2.92
-17%
|
-34.66
N/A
|
-32.98
+5%
|
-34.38
-4%
|
-33.38
+3%
|
-31.75
+5%
|
-31.16
+2%
|
-30.52
+2%
|
-28.97
+5%
|
|
Switch to:
Switch to:
See Also
Discover More
